Definitive Contract HHSN261201300026C
Award Date 9/20/13
Potential Completion Date 7/5/14
Potential Value $279K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pensacola, FL 32505, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a Firm Fixed Price Definitive Contract to Vivo Biosciences, Inc. for the "SBIR PHASE I NEW 3D HUBIOGEL CULTURE SYSTEM FOR CANCER STEM CELLS EXPANSION & ANALYSIS" project. The contract has a ceiling value of $219,812.00 and the ultimate completion date is July 21, 2016. This is a Small Business Innovation Research (SBIR) Phase I contract, which supports early-stage research and development of innovative technologies. The contract does not have a...
- This is a federal contract award to Vivo Biosciences, Inc., a small business, by the National Cancer Institute (NCI) with a ceiling value of $1,882,456.20. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and an ultimate completion date of October 16, 2017. The contract was awarded on September 22, 2015 and has a "Total Small Business" set-aside designation. Based on the description, this contract is likely related to the NCI's biomedical research and...
- This definitive contract from the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH) is valued at $392,519 to Vivosense Inc. for SBIR Topic 412: Vivosense Cancer Health Informatics Platform, Phase I. The contract is a firm fixed price award set aside for total small business under the SBIR solicitation seeking proposals for Phase I and Phase II contracts to conduct research and development supporting NIH and CDC agency missions. This...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...
- This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- <p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract is for the development of glycosylation-specific research under SBIR Topic 294, with a ceiling value of $148,569. SBIR contracts are set-aside for small businesses to engage in research and development for the government. This Phase I contract represents the initial research and feasibility...
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Biosensics LLC, a small business located in Newtonville, Massachusetts. The contract is for the development of an automated screening platform to enable early identification of malnutrition in cancer patients. This contract award is part of the FY24 SBIR solicitation, which covers a variety of research topics...
- <p>This is a $199,969 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Accelerated Medical Diagnostics, Inc. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a firm fixed price pricing type with a completion date of September 30, 2016. As an SBIR Phase I award, this contract supports early-stage research and development activities.</p>